Who owns Taro Pharmaceutical Industries?
- Ticker: TARO
- CUSIP Number: M8737E108
Tip: Access positions for across all investors
Analyze quarterly positions in Taro Pharmaceutical Industries with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Taro Pharmaceutical Industries stock
Who bought or sold Taro Pharmaceutical Industries this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Krensavage Asset Management | 647k | $27M | 1% | Dec 2023 |
|
| Dimensional Fund Advisors | 546k | $23M | -1% | Dec 2023 |
|
| Brandes Investment Partners | 476k | $20M | 1% | Dec 2023 |
|
| Vanguard Group | 51k | $2.1M | 6% | Dec 2023 |
|
| ARK Investment Management | 50k | $2.1M | -9% | Mar 2024 |
|
| Norges Bank Investment Management | 43k | $1.8M | 100% | Dec 2023 |
|
| Arrowstreet Capital, Limited Partnership | 40k | $1.7M | -44% | Dec 2023 |
|
| UBS Group | 37k | $1.5M | -32% | Dec 2023 |
|
| Bank of New York Mellon | 22k | $950k | -1% | Mar 2024 |
|
| Charles Schwab Investment Management | 19k | $781k | 0% | Dec 2023 |
|
| Swiss National Bank | 19k | $777k | -11% | Dec 2023 |
|
| Citadel Advisors | 15k | $630k | -33% | Dec 2023 |
|
| Barclays | 15k | $607k | 202% | Dec 2023 |
|
| Connor, Clark & Lunn Investment Management | 14k | $600k | 27% | Dec 2023 |
|
| Inspire Advisors | 14k | $572k | 28% | Dec 2023 |
|
| Analyst IMS Investment Management Services | 14k | $566k | 0% | Dec 2023 |
|
| Credit Suisse | 13k | $549k | 13% | Dec 2023 |
|
| OTR - Nominee Name for The State Teachers Retirement Board of Ohio | 13k | $547k | 385% | Dec 2023 |
|
| Martingale Asset Management | 12k | $519k | 13% | Dec 2023 |
|
| Schonfeld Strategic Advisors | 11k | $459k | 69% | Dec 2023 |
|
| D. E. Shaw & Co | 10k | $432k | 4% | Dec 2023 |
|
| Rhumbline Advisers | 9.4k | $391k | -4% | Dec 2023 |
|
| Bank of America Corporation | 9.2k | $383k | -17% | Dec 2023 |
|
| Legal & General Group | 8.7k | $362k | 5% | Dec 2023 |
|
| Winton Capital | 7.3k | $307k | 3% | Dec 2023 |
|
| Two Sigma Advisers | 7.3k | $305k | -44% | Dec 2023 |
|
| Crystalline Management | 7.1k | $297k | 100% | Dec 2023 |
|
| Hrt Financial | 7.0k | $294k | 100% | Dec 2023 |
|
| Metis Global Partners | 6.9k | $290k | 0% | Dec 2023 |
|
| Ubs Global Asset Management Americas | 6.5k | $271k | 18% | Dec 2023 |
|
| Jpmorgan Chase & Co | 6.4k | $265k | -1% | Dec 2023 |
|
| Goldman Sachs Group | 5.6k | $236k | -68% | Dec 2023 |
|
| Alliancebernstein | 5.3k | $223k | 100% | Dec 2023 |
|
| Deutsche Bank Aktiengesellschaft | 5.3k | $220k | -16% | Dec 2023 |
|
| SG Americas Securities | 4.7k | $195k | 25% | Dec 2023 |
|
| MetLife Investment Advisors | 4.3k | $181k | 0% | Dec 2023 |
|
| American International | 4.1k | $170k | 0% | Dec 2023 |
|
| New York State Common Retirement Fund | 3.2k | $134k | -3% | Dec 2023 |
|
| Van Eck Associates Corp. | 2.8k | $119k | -3% | Dec 2023 |
|
| Wells Fargo & Company | 2.8k | $115k | 22% | Dec 2023 |
|
| FNY Investment Advisers | 2.5k | $105k | 100% | Dec 2023 |
|
| Bnp Paribas Arbitrage, Snc | 2.3k | $96k | 88% | Dec 2023 |
|
| PenderFund Capital Management | 2.2k | $122k | 100% | Dec 2023 |
|
| Royal Bank of Canada | 2.0k | $83k | -2% | Dec 2023 |
|
| Signature | 1.3k | $55k | -1% | Dec 2023 |
|
| Advisor Group Holdings | 1.3k | $54k | 253% | Dec 2023 |
|
| Citigroup | 1.2k | $50k | 7807% | Dec 2023 |
|
| Zurcher Kantonalbank | 986.00 | $42k | 100% | Mar 2024 |
|
| Gladius Capital Management | 882.00 | $37k | 9% | Dec 2023 |
|
| Quadrant Capital | 740.00 | $31k | 38% | Dec 2023 |
|
| Summit Investment Advisors | 675.00 | $28k | 0% | Dec 2023 |
|
| Metropolitan Life Insurance Company | 449.00 | $19k | 0% | Dec 2023 |
|
| Harel Insurance Investments & Financial Services | 397.00 | $17k | -30% | Dec 2023 |
|
| Amalgamated Bank | 276.00 | $12k | -61% | Mar 2024 |
|
| Us Bancorp | 230.00 | $9.6k | -82% | Dec 2023 |
|
| Washington Trust Advisors | 200.00 | $8.4k | 0% | Dec 2023 |
|
| ADAR1 Capital Management | 200.00 | $8.4k | 100% | Dec 2023 |
|
| Lindbrook Capital | 142.00 | $6.0k | 0% | Mar 2024 |
|
| Harbour Investments | 50.00 | $2.1k | 0% | Dec 2023 |
|
| Ronald Blue Trust | 28.00 | $1.0k | 100% | Dec 2023 |
|
| Private Wealth Management Group | 26.00 | $1.1k | 100% | Dec 2023 |
|
| Covestor | 18.00 | $1.0k | -36% | Dec 2023 |
|
| CWM | 15.00 | $1.0k | 67% | Mar 2024 |
|
| GAMMA Investing | 14.00 | $592.999400 | 600% | Mar 2024 |
|
| NISA Investment Advisors | 13.00 | $542.999600 | 0% | Dec 2023 |
|
| Farther Finance Advisors | 7.00 | $292.000100 | 0% | Dec 2023 |
|
| Advisory Services Network | 6.00 | $250.999800 | 100% | Dec 2023 |
|
Who sold out of Taro Pharmaceutical Industries?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Cowen And Company | Sep 2023 | 69k | $2.6M |
| Alpine Partners VI | Sep 2023 | 8.2k | $308k |
| Allspring Global Investments Holdings | Dec 2023 | 7.5k | $312k |
| DLD Asset Management | Sep 2023 | 5.7k | $215k |
| Parallel Advisors | Sep 2023 | 22.00 | $830.000600 |